2025-04-05 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Review

**0) Key Figures:**

* **Cumulative Return (ISRG):** 124.88%
* **Cumulative Return (VOO/S&P 500):** 71.02%
* **Return Difference:** 53.86%
* **Relative Divergence:** 40.7% (Indicates ISRG's performance is significantly above the S&P 500, but within its historical range of outperformance)
* **Current Price:** $451.58
* **Market Risk Indicator (MRI):** 0.4693 (High Risk)


**1) Company Overview and Performance Comparison:**

Intuitive Surgical Inc. is a leading manufacturer of robotic surgical systems.  Over the reviewed period, ISRG significantly outperformed the S&P 500 (VOO), achieving a cumulative return of 124.88% compared to VOO's 71.02%.  The 53.86% difference is substantial, although the relative divergence of 40.7% suggests this level of outperformance is within the historical range of its relative performance compared to the S&P 500. The provided alpha and beta data shows a generally positive alpha (outperformance relative to the market) and a beta that has fluctuated over time.  The increasing market capitalization (Cap(B)) reflects the company's growth.


**Alpha and Beta Analysis:**

The provided data shows a mixed picture. While recent years (2021-2023) show a significantly higher beta (1.1) than prior years, suggesting increased volatility, the alpha is also high, signifying consistent outperformance during that period. However, 2023-2025 shows the alpha dropping to 0.8. Overall,  ISRG has demonstrated above-market returns (positive alpha), but with some periods of heightened volatility (beta).


**2) Recent Price Movement:**

* **Closing Price:** $451.58
* **5-day Moving Average:** $488.97
* **20-day Moving Average:** $493.30
* **60-day Moving Average:** $549.95

The stock price is currently trading below all three moving averages, suggesting a short-term downtrend. The recent price drop of $8.7 (-8.7%) compared to previous closing price is significant and contributed to this downtrend.


**3) Technical Indicators and Expected Return:**

* **RSI:** 36.69 (Suggests the stock is currently in oversold territory)
* **PPO:** -0.0841 (Negative PPO indicates bearish momentum.)
* **20-Day Relative Divergence Change:** -2.3% (Short-term downtrend)
* **Expected Return:** 58.3% (Over two years, this represents a significant outperformance expectation compared to the S&P 500)
* **Market Risk Indicator (MRI):** 0.4693, categorized as High Risk.  This reflects the current market volatility and the recent significant price drop.

The significant negative change in price (-$8.7) and the oversold RSI suggest a potential for a rebound, but the negative PPO and High MRI indicate caution.  The high expected return is promising, but should be considered in the context of the substantial risk, as reflected in the MRI and the price action.


**4) Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-10-18 | $1.59 | $2.04 Billion |
| 2024-07-19 | $1.48 | $2.01 Billion |
| 2024-04-19 | $1.54 | $1.89 Billion |
| 2023-10-20 | $1.18 | $1.74 Billion |
| 2023-10-18 | $1.18 | $1.74 Billion | *(Duplicate Entry)*


Revenue shows a steady increase, although there's some minor quarter-to-quarter fluctuation. EPS also shows growth, but the duplicate entry makes this analysis slightly ambiguous.  More data is needed for a thorough analysis.  Note the potential for error in the data provided.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|------------|---------------|
| 2024-12-31 | $2.41B     | 68.04%        |
| 2024-09-30 | $2.04B     | 67.41%        |
| 2024-06-30 | $2.01B     | 68.30%        |
| 2024-03-31 | $1.89B     | 65.87%        |
| 2023-12-31 | $1.93B     | 66.24%        |

Revenue is steadily increasing, showing strong growth. Profit margins are consistently high, indicating good profitability.


**Capital and Profitability:**

| Quarter     | Equity     | ROE      |
|-------------|------------|-----------|
| 2024-12-31 | $16.43B    | 4.17%    |
| 2024-09-30 | $15.58B    | 3.63%    |
| 2024-06-30 | $14.71B    | 3.58%    |
| 2024-03-31 | $13.96B    | 3.90%    |
| 2023-12-31 | $13.31B    | 4.56%    |

Equity is growing, indicating strong financial health. ROE fluctuates slightly but remains relatively healthy.


**6) Overall Analysis:**

ISRG has demonstrated significant outperformance compared to the S&P 500 over the long term.  However, the recent price drop and high market risk indicator suggest a period of increased volatility and potential short-term risk. While the company's fundamentals, as indicated by its revenue, profitability, and equity growth, remain strong, the current market sentiment and technical indicators suggest caution in the short term.  The high projected long-term return warrants consideration, but investors should carefully weigh the potential for further short-term price corrections given the current high risk level.  A thorough examination of the reasons for the recent price drop is crucial before making any investment decisions.  The presence of duplicate data in the earnings analysis should be investigated further for potential data errors.
